| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 08/02/2011 | US7989490 Injectable formulations of taxanes for cad treatment |
| 08/02/2011 | US7989459 Purinones and 1H-imidazopyridinones as PKC-theta inhibitors |
| 08/02/2011 | US7988965 Methods of treating systemic lupus erythematosus with an antibody against costimulatory signal transduction molecule ailim |
| 08/02/2011 | US7988952 Condensation aerosol formed by heating a thin layer containing the ester, on a solid support to produce a vapor of the ester, and condensing; less than 10% ester degradation products by weight, and a Mass median aerodynamic diameter of less than 5 microns |
| 08/02/2011 | CA2518885C Pharmaceutical composition for intracellular acidification with cis-urocanic |
| 08/02/2011 | CA2496538C Boronic ester and acid compounds, synthesis and uses |
| 08/02/2011 | CA2489209C New derivatives of arylsulfonamides and use thereof in therapy |
| 08/02/2011 | CA2486678C Non-viral gene delivery system |
| 08/02/2011 | CA2475780C 1-phenyl-2-heteroaryl-substituted benzimidazole derivatives, their use to prepare drugs for treatment of immunological diseases |
| 08/02/2011 | CA2449634C Somatostatin-dopamine chimeric analogs |
| 08/02/2011 | CA2447632C Fusion protein agonist comprising a growth hormone binding portion and an external domain of a growth hormone receptor |
| 08/02/2011 | CA2447010C Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 08/02/2011 | CA2442682C Monocyte-specific particulate delivery vehicle |
| 08/02/2011 | CA2441690C Method for the identification of antigenic peptides |
| 08/02/2011 | CA2427964C Method and preparations having effect against allergic symptoms |
| 08/02/2011 | CA2417984C Methods for treating autoimmune and chronic inflammatory conditions using antagonists of cd30 or cd30l |
| 08/02/2011 | CA2395593C Azaindoles |
| 08/02/2011 | CA2323207C Food products having enhanced cocoa polyphenol content and processes for producing same |
| 07/28/2011 | WO2011091401A2 Treatment of immune disorders using kainate receptor antagonists |
| 07/28/2011 | WO2011091376A2 Immunogenic influenza composition |
| 07/28/2011 | WO2011091027A2 Recombinant live attenuated foot-and-mouth disease (fmd) vaccine containing mutations in the l protein coding region |
| 07/28/2011 | WO2011090973A2 Immunotherapy compositions and methods of treatment |
| 07/28/2011 | WO2011090926A1 Nutritional formulas containing synbiotics |
| 07/28/2011 | WO2011090762A1 Heterodimer binding proteins and uses thereof |
| 07/28/2011 | WO2011090761A1 Ron binding constructs and methods of use thereof |
| 07/28/2011 | WO2011090754A1 Polypeptide heterodimers and uses thereof |
| 07/28/2011 | WO2011090062A1 Piperazine compound having a pgds inhibitory effect |
| 07/28/2011 | WO2011089396A2 Pyruvamide compounds as inhibitors of dust mite group 1 peptidase allergen and their use. |
| 07/28/2011 | WO2011054939A3 Compositions and methods for inhibiting expression of kif10 genes |
| 07/28/2011 | US20110184145 Method of administering therapeutic polypeptides, and polypeptides therefor |
| 07/28/2011 | US20110184038 Methods and compositions of small molecule modulators of hepatocyte growth factor (scatter factor) activity |
| 07/28/2011 | US20110184034 Severe sepsis preventive therapeutic agent |
| 07/28/2011 | US20110184010 Method of treating mantle cell lymphoma |
| 07/28/2011 | US20110183997 Heterocyclic compounds and compositions as c-kit and pdgfr kinase inhibitors |
| 07/28/2011 | US20110183985 Substituted fused aryl and heteroaryl derivatives as pi3k inhibitors |
| 07/28/2011 | US20110183977 Benzene, pyridine, and pyridazine derivatives |
| 07/28/2011 | US20110183973 Novel Compounds |
| 07/28/2011 | US20110183967 Benzoxazole compounds and methods of use |
| 07/28/2011 | US20110183952 New chemical compounds |
| 07/28/2011 | US20110183930 Water soluble and activable phenolics derivatives with dermocosmetic and therapeutic applications and process for preparing said derivatives |
| 07/28/2011 | US20110183924 Methods and systems for annotating biomolecular sequences |
| 07/28/2011 | US20110183923 Peptide antagonists of zonulin and methods for use of the same |
| 07/28/2011 | US20110183921 Peptides capable of modulating the function of tirc7 |
| 07/28/2011 | US20110183908 Yopm as delivery vehicle for cargo molecules and as biological therapeutic for immunomodulation of inflammatory reactions |
| 07/28/2011 | US20110182993 Film-form preparation |
| 07/28/2011 | US20110182981 Gonococcal vaccines |
| 07/28/2011 | US20110182975 Method of conferring a protective immune response to norovirus |
| 07/28/2011 | US20110182964 Vascular Stent Which Elutes Amino Acid-Methyl-Ester Derivatives for the Treatment of Vulnerable Plaque and Vascular Disease |
| 07/28/2011 | US20110182943 Methods of immune or hematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer, cancer symptoms, or the symptoms of cancer treatments |
| 07/28/2011 | US20110182942 Meningococcal multivalent native outer membrane vesicle vaccine, methods of making and use thereof |
| 07/28/2011 | US20110182940 Method for producing purified influenza virus antigen |
| 07/28/2011 | US20110182939 Vaccine Adjuvants |
| 07/28/2011 | US20110182937 Dendritic Cell Vaccines |
| 07/28/2011 | US20110182934 Immune system stimulating nutrition |
| 07/28/2011 | US20110182933 Modified vaccinia ankara virus variant |
| 07/28/2011 | US20110182932 Modified vaccinia ankara virus variant |
| 07/28/2011 | US20110182931 Immortal avian cell line and methods of use |
| 07/28/2011 | US20110182929 Multicomponent vaccine for malaria providing long-lasting immune responses against plasmodia |
| 07/28/2011 | US20110182927 Inhibitors of DNA Immunostimulatory Sequence Activity |
| 07/28/2011 | US20110182926 Minigene |
| 07/28/2011 | US20110182925 Ehrlichia canis DIVA (Differentiate Infected from Vaccinated Animals) |
| 07/28/2011 | US20110182923 Novel group b streptococcus antigens |
| 07/28/2011 | US20110182922 Peptides of il1 beta and tnf alpha and method of treatment using same |
| 07/28/2011 | US20110182921 Regulatory t cell epitopes, compositions and uses thereof |
| 07/28/2011 | US20110182920 Identification of a novel cysteine-rich cell penetrating peptide |
| 07/28/2011 | US20110182908 Diagnostics and Therapeutics for Macular Degeneration-Related Disorders |
| 07/28/2011 | US20110182903 Novel soluble cd83 polypeptides, formulations and methods of use |
| 07/28/2011 | US20110182902 Recombination Sequence (RS) Rearrangement Frequency as a Measure of Central B Cell Tolerance |
| 07/28/2011 | US20110182901 Full length large t tumor antigen of merkel cell polyomavirus as a therapeutic target in merkel cell carcinoma |
| 07/28/2011 | US20110182898 Immunosuppressive polypeptides and nucleic acids |
| 07/28/2011 | US20110182897 Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases |
| 07/28/2011 | US20110182894 Methods of treating diabetes using IL-1beta antibodies |
| 07/28/2011 | US20110182893 Prevention and treatment of amyloidogenic diseases |
| 07/28/2011 | US20110182889 Compositions and methods for the treatment of natural killer cell related diseases |
| 07/28/2011 | US20110182870 Generation of ctl lines with specificity against multiple tumor antigens or multiple viruses |
| 07/28/2011 | US20110182856 Inhibitors of serine proteases |
| 07/28/2011 | US20110182848 Granulocyte colony stimulating factor |
| 07/28/2011 | US20110182847 Use of tlr agonists and/or type 1 interferons to alleviate toxicity of tnf-r agonist therapeutic regimens |
| 07/28/2011 | US20110182828 C20-c21 substituted glucocorticoid receptor agonists |
| 07/28/2011 | US20110182805 Nanoparticle fabrication methods, systems, and materials |
| 07/28/2011 | US20110180430 Adjuvanted influenza vaccines including cytokine-inducing agents |
| 07/28/2011 | CA2787974A1 Immunogenic influenza composition |
| 07/28/2011 | CA2787248A1 Piperazine compound having a pgds inhibitory effect |
| 07/28/2011 | CA2786690A1 Pyruvamide compounds as inhibitors of dust mite group 1 peptidase allergen and their use |
| 07/28/2011 | CA2785907A1 Ron binding constructs and methods of use thereof |
| 07/28/2011 | CA2785661A1 Polypeptide heterodimers and uses thereof |
| 07/28/2011 | CA2784814A1 Heterodimer binding proteins and uses thereof |
| 07/28/2011 | CA2729484A1 Film-form preparation |
| 07/27/2011 | EP2348134A1 RNA interference mediating small RNA molecules |
| 07/27/2011 | EP2348133A1 RNA interference mediating small RNA molecules |
| 07/27/2011 | EP2348048A1 Antagonistic Anti-HTNFSF13B Human Antibodies |
| 07/27/2011 | EP2348043A1 APO-2 ligand variants and uses thereof |
| 07/27/2011 | EP2348036A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 07/27/2011 | EP2348035A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 07/27/2011 | EP2348034A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 07/27/2011 | EP2348032A2 6.Alpha.,9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl) oxy]-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothiotic acid s-fluoromethyl ester as an anti-inflammatory agent |
| 07/27/2011 | EP2348023A1 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors |
| 07/27/2011 | EP2347767A2 Immune regulation based on the targeting of early activation molecules |
| 07/27/2011 | EP2347766A1 Use of TNFalpha antibodies and another drug |
| 07/27/2011 | EP2346867A1 Phosphodiestarase inhibitors |